PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
16-Dec-2022 Beiersdorf acquires S-Biomedic and strengthens expertise in the field of acne treatment Beiersdorf
16-Dec-2022 CSL Receives Positive CHMP Opinion for Etranacogene Dezaparvovec – Gene Therapy for Adults with Hemophilia B CSL
16-Dec-2022 RevoluGen Announces Distribution Agreement with BioEntist for Fire Monkey HMW-DNA Extraction Products in Thailand RevoluGen
16-Dec-2022 Alchemab Therapeutics and Medicines Discovery Catapult awarded £1.7 million grant from Innovate UK to accelerate development of disease-modifying therapy for Huntington’s Disease Alchemab Therapeutics
16-Dec-2022 Sosei Heptares and Lilly Enter Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases Sosei Heptares
16-Dec-2022 ABPI response to Government's future strategy for batch testing of medicinal products in Great Britain ABPI
16-Dec-2022 Transgene Announces Upcoming Investor Meetings Transgene
16-Dec-2022 DATWYLER ADDS STEAM STERILIZATION OPTION FOR READY-TO-USE COMPONENTS FOR INJECTABLE DRUGS DATWYLER
16-Dec-2022 Envirotainer celebrates a decade of success in the APAC region Envirotainer
16-Dec-2022 CAS INTRODUCING TRANSFORMATIONAL CAPABILITIES TO ACCELERATE LIFE SCIENCES INNOVATION CAS
16-Dec-2022 New Study Shows Comprehensive Genomic Evidence is Critical for Calculating Rare Disease Prevalence Genomenon, Inc.,
16-Dec-2022 Weekly Pharma & Life Science News Round-Up: 12th – 16th December 2022 PharmiWeb.Jobs
16-Dec-2022 Velocity Clinical Research acquires Meridian Clinical Research creating largest global research sites business Velocity Clinical Research
16-Dec-2022 UK medicines revenue clawback rockets to 26.5% putting Life Sciences Vision at risk, says ABPI ABPI
16-Dec-2022 Cherwell to demonstrate new EM product pipeline at Pharmaceutical Microbiology Europe conference Cherwell
16-Dec-2022 Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for prurigo nodularis Sanofi
16-Dec-2022 Cutting-edge protein design project to join BioInnovation Institute’s Bio Studio program BioInnovation Institute (BII)
16-Dec-2022 MinervaX announces 72M EUR financing to advance development of novel vaccine against Group B Streptococcus MinervaX
16-Dec-2022 PAION AG issues statement on planned capital measure PAION AG
16-Dec-2022 Heidelberg Pharma Signs Research and Exclusive Option Agreement with Binghamton University on Immunostimulatory Technology Platform Heidelberg Pharma AG